We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RENE market cap is 1.74M. The company's latest EPS is GBP -0.0946 and P/E is -0.32.
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 2.72M | 6.17M | 335k | 403k | 530k |
Operating Income | -18.3M | -14.41M | -12.91M | -11.23M | -7.12M |
Net Income | -14.35M | -11.41M | -11.35M | -9.69M | -5.41M |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 31.51M | 20.38M | 25.35M | 17.32M | 9.65M |
Total Liabilities | 8.27M | 7.15M | 6.45M | 7.44M | 4.59M |
Total Equity | 23.24M | 13.22M | 18.91M | 9.89M | 5.06M |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -11.95M | -14.3M | -6.05M | -7.41M | -7.48M |
Investing | 103k | 181k | 2k | 2.22M | 3.91M |
Financing | 4.37M | 6.32M | 8.61M | -134k | -147k |
Market Cap | 1.74M |
Price to Earnings Ratio | -0.32 |
Price to Sales Ratio | 3.28 |
Price to Cash Ratio | 0.28 |
Price to Book Ratio | 0.34 |
Dividend Yield | - |
Shares Outstanding | 57.17M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -67.03% |
52 Week High | 10.25 |
52 Week Low | 2.95 |
Spread (Intraday) | 0 (0%) |
Company Name | Reneuron Group Plc |
Address |
pencoed business park london CF35 5HY |
Website | https://www.reneuron.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions